# Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors

> **NCT01342237** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 33 (estimated)

## Conditions studied

- Brain Tumors

## Interventions

- **DRUG:** HDCT 1(TTC), HDCT2(MEC)

## Key facts

- **NCT ID:** NCT01342237
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2013-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01342237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01342237, "Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01342237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*